894 followers
RT @MedicalEvidence: The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients…
RT @MedicalEvidence: The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients…
The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review https://t.co/nIk45toU0P